Chalcone-9 demonstrated significant anti-cancer activity, particularly against TNBC. By targeting the JAK/STAT pathway and promoting apoptosis, chalcone-9 emerged as a promising therapeutic candidate for aggressive breast cancers.
[Pharmacological Reports]